J Korean Med Sci.  2007 Apr;22(2):262-269. 10.3346/jkms.2007.22.2.262.

Modified Acellularization for Successful Vascular Xenotransplantation

  • 1Department of Thoracic and Cardiovascular Surgery, Ansan Hospital, Korea University, Ansan, Korea.
  • 2Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Korea University, 80 Guro-dong, Guro-gu, Seoul, Korea. sohnys@korea.ac.kr
  • 3Department of Pathology, Cheonan Hospital, Soonchunhyang University, Cheonan, Korea.


The purpose of this study was to estimate the possibilities of an acellular matrix using a modified acellularization protocol, which circumvents immunological, microbiological, and physiological barriers. We treated porcine subclavian arteries with various reagents to construct acellular grafts. Afterwards, these grafts were interposed in a mongrel dogs' abdominal aorta. Six dogs underwent interposition with fresh porcine grafts (control group), and seven had interposed acellular grafts (acellular group). The control and acellular group dogs were sacrificed at 1, 3, 5 (n=2 in each group) and 12 months (n=1 in acellular group) after the operation. Histopathological examinations were then performed, to assess the degree to which re-endothelialization, inflammation, thrombus formation, and calcification occurred. The entire acellular group, but none of the control group, exhibited re-endothelialization. The degrees to which inflammation, thrombosis, and calcification occurred were found to be lower in the acellular group. We also discovered many smooth muscle cells in the medial layer of the xenograft that had been implanted in the dog sacrificed 12 months after the operation. These results suggest that the construction of xenografts using our modified acellularization protocol may offer acceptable outcomes as a vascular xenograft.


Xenograft; Vascular Endothelial Cell; Graft Rejection
Full Text Links
  • JKMS
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr